Letters Non-commercial clinical trials

A step change in operational performance is needed

BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c5472 (Published 13 October 2010) Cite this as: BMJ 2010;341:c5472
  1. Jon Moulton, trustee ,
  2. Ashley Woodcock, head of School of Translational Medicine, University of Manchester,
  3. Helen P Critchley, senior clinical research associate
  1. 1JP Moulton Charitable Foundation, Sevenoaks, Kent TN14 7SD, UK
  1. hpcritchley{at}yahoo.com

The JP Moulton Charitable Foundation began funding non-commercial clinical trials in April 2004. Applications had to demonstrate good scientific rationale, expertise in the area of research, clear budget breakdowns, and achievable targets. If funding was approved, the foundation requested a detailed breakdown of costs, milestones for payment against recruitment, detailed quarterly progress reports, and …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe